ASCO News
Most Popular ASCO Story
ASCO hightlights Herceptin, PARP inhibitors
There's no shortage of cancer news this morning, thanks to the annual ASCO meeting. One drug that's getting a lot of press is Roche's blockbuster breast cancer biologic Herceptin. In patients with... Read more...
Latest Headlines
- June 2, 2009
- June 1, 2009
- May 29, 2009
- May 15, 2009
- January 15, 2009
- June 3, 2008
- June 2, 2008
- May 30, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
